Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Capper, Michael, O'Neill, Paul ORCID: 0000-0003-4338-0317, Fisher, Nicholas, Strange, Richard, Moss, Darren, Ward, Stephen, Berry, Neil ORCID: 0000-0003-1928-0738, Lawrenson, Alexandre, Hasnain, Samar, Biagini, Giancarlo
et al (show 1 more authors) (2015) Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1. Proceedings of the National Academy of Sciences of the United States of America, 112 (3). 755 - 760.


Jirawatcharadech, P
(2019) Characterisation of Plasmodium falciparum NADPH-dependent diflavin reductase I (PfDFR1) and its role in primaquine mechanism of action. PhD thesis, University of Liverpool.


Unwin, Vera
(2020) Development and evaluation of diagnostics for malaria control. PhD thesis, University of Liverpool.


Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Pertinez, Henry, Arshad, Usman ORCID: 0000-0003-1586-1885, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan ORCID: 0000-0002-4960-2139, Sharp, Joanne, Liptrott, Neill J ORCID: 0000-0002-5980-8966, Valentijn, Anthony
et al (show 13 more authors) (2021) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (4). 2078 - 2088.


Rajoli, Rajith Kr, Pertinez, Henry, Arshad, Usman, Box, Helen, Tatham, Lee ORCID: 0000-0001-9448-8876, Curley, Paul, Neary, Megan, Sharp, Joanne, Liptrott, Neill J, Valentijn, Anthony
et al (show 13 more authors) (2020) Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. medRxiv : the preprint server for health sciences.


Mubaraki, Murad
Pharmacometabolomic study of the human malaria parasite, Plasmodium falciparum: new insights into parasite biology and mode of drug action. [Unspecified]


Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee, Rajoli, Rajith KR, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan, Sharp, Joanne, Liptrott, Neill, Valentijn, Anthony
et al (show 11 more authors) (2020) Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics.


Clark, Jordan, Penrice-Randal, Rebekah, Sharma, Parul, Kipar, Anja, Dong, Xiaofeng, Pennington, Shaun, Marriott, Amy, Colombo, Stefano, Davidson, Andrew, Williamson, Maia Kavanagh
et al (show 15 more authors) (2020) Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19.

This list was generated on Sat May 8 22:14:19 2021 BST.